RACGAP1 and cancer: On the other hand, analysis of NKT cell infiltration, a cell that has a strong antitumor action and was selected as a target for cancer immunotherapy development [18], demonstrated that more than 70% of the analyzed tumors experienced a negative correlation between RACGAP1 expression and NKT cell infiltration (Figure 7B).